These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24966915)

  • 21. Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.
    Besso MJ; Montivero L; Lacunza E; Argibay MC; Abba M; Furlong LI; Colas E; Gil-Moreno A; Reventos J; Bello R; Vazquez-Levin MH
    Oncol Rep; 2020 Sep; 44(3):873-886. PubMed ID: 32705231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
    Steiner E; Eicher O; Sagemüller J; Schmidt M; Pilch H; Tanner B; Hengstler JG; Hofmann M; Knapstein PG
    Int J Gynecol Cancer; 2003; 13(2):197-203. PubMed ID: 12657124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
    Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
    Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of CUB domain containing protein expression in endometrioid adenocarcinoma.
    Mamat S; Ikeda J; Enomoto T; Ueda Y; Rahadiani N; Tian T; Wang Y; Qiu Y; Kimura T; Aozasa K; Morii E
    Oncol Rep; 2010 May; 23(5):1221-7. PubMed ID: 20372833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas.
    Werner HM; Berg A; Wik E; Birkeland E; Krakstad C; Kusonmano K; Petersen K; Kalland KH; Oyan AM; Akslen LA; Trovik J; Salvesen HB
    Mod Pathol; 2013 Mar; 26(3):428-34. PubMed ID: 23080032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.
    Ni J; Zhu T; Zhao L; Che F; Chen Y; Shou H; Yu A
    Clin Transl Oncol; 2015 Oct; 17(10):835-9. PubMed ID: 26260911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
    Deng YF; Zhou DN; Pan ZY; Yin P
    Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.
    Pansare V; Munkarah AR; Schimp V; Haitham Arabi M; Saed GM; Morris RT; Ali-Fehmi R
    Mod Pathol; 2007 Jan; 20(1):35-43. PubMed ID: 17099695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.
    Banas T; Pitynski K; Okon K; Winiarska A
    BMC Cancer; 2018 Apr; 18(1):418. PubMed ID: 29653556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of LncRNA FER1L4 in endometrial carcinoma is associated with favorable survival outcome.
    Kong Y; Ren Z
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8113-8118. PubMed ID: 30556848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parametrial spread is a prognostic factor in endometrial carcinoma.
    Sato R; Jobo T; Kuramoto H
    Eur J Gynaecol Oncol; 2003; 24(3-4):241-5. PubMed ID: 12807232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.
    AlHilli MM; Mariani A; Bakkum-Gamez JN; Dowdy SC; Weaver AL; Peethambaram PP; Keeney GL; Cliby WA; Podratz KC
    Gynecol Oncol; 2014 Jun; 133(3):485-93. PubMed ID: 24690476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
    Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
    Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant expression of ezrin and HER2 predicts distant metastasis and poor prognosis of patients with salivary gland carcinomas.
    Hashimoto K; Hayashi R; Mukaigawa T; Yamazaki M; Fujii S
    Hum Pathol; 2017 May; 63():110-119. PubMed ID: 28300573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
    Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
    Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
    Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
    Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhu YH; Yang F; Zhang SS; Zeng TT; Xie X; Guan XY
    Int J Clin Exp Pathol; 2013; 6(11):2497-505. PubMed ID: 24228112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.